Loss of miR‑873 contributes to gemcitabine resistance in triple‑negative breast cancer via targeting ZEB1

Gangyue Wang(Capital Medical University), Yu Ren(Chongqing University)

Oncology Letters

August 1, 2019

10.3892/ol.2019.10697

Cited by 21

Related Papers

Germline mutations in 40 cancer susceptibility genes among <scp>C</scp>hinese patients with high hereditary risk breast cancer

|International Journal of Cancer|2018|61

Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States

|Cancer|2012|37

The features of male breast cancer in China: A real-world study

|The Breast|2024|10